Filtered By:
Source: Clinical Pharmacist
This page shows you your search results in order of date.
Order by Relevance | Date
Total 19 results found since Jan 2013.
Fluoxetine does not assist recovery following stroke, research suggests
Daily fluoxetine in patients who have had a stroke does not improve functional outcomes at six months, results of a randomised trial published in The Lancet have shown.
Source: Clinical Pharmacist - January 21, 2019 Category: Drugs & Pharmacology Source Type: research
People with dementia less likely to receive oral anticoagulants despite stroke risk
People with atrial fibrillation who have dementia are less likely to receive oral anticoagulants (OACs) than those without cognitive impairment, research has shown.
Source: Clinical Pharmacist - October 1, 2018 Category: Drugs & Pharmacology Source Type: research
Omega-3 supplements do not protect against cardiovascular disease, meta-analysis shows
A meta-analysis of 79 trials showed that increasing long-chain omega-3 had little or no effect on death from all causes, cardiovascular deaths, cardiovascular events, coronary heart disease deaths, stroke or arrhythmia.
Source: Clinical Pharmacist - August 31, 2018 Category: Drugs & Pharmacology Source Type: research
Pharmacists in a multidisciplinary atrial fibrillation clinic
Atrial fibrillation (AF) is the most common cardiac rhythm disturbance and increases in prevalence with advancing age. Each year, Tallaght University Hospital in Dublin assesses and admits over 400 patients with stroke and transient ischemic attack. AF is implicated as a causative factor in 33% of these cases. An AF-related stroke is more likely to be fatal, disabling and recurrent than a non-AF related stroke. The risk of AF-related stroke is greatly reduced, however, by early detection ...
Source: Clinical Pharmacist - July 30, 2018 Category: Drugs & Pharmacology Source Type: research
Clopidogrel plus aspirin reduces stroke risk in patients with ischaemic events
The incidence of major ischaemic events is reduced in at-risk patients if clopidogrel is given alongside aspirin, study finds.
Source: Clinical Pharmacist - July 4, 2018 Category: Drugs & Pharmacology Source Type: research
Aspirin lowers risk of death in people with concomitant heart failure and diabetes
Aspirin reduces the risk of all-cause death or hospitalisation for heart failure in patients with concomitant type 2 diabetes and heart failure but increases the risk of non-fatal heart attack or stroke.
Source: Clinical Pharmacist - June 22, 2018 Category: Drugs & Pharmacology Source Type: research
Rheumatoid arthritis drug may reduce inflammation after stroke
The pro-inflammatory cytokine interleukin-1 plays a significant role in brain injury following ischemic stroke by inducing peripheral inflammatory mediators, such as interleukin-6. However, pre-clinical studies show its effects are reduced by the interleukin-1 receptor antagonist.
Source: Clinical Pharmacist - May 14, 2018 Category: Drugs & Pharmacology Source Type: research
Uncertainty over anticoagulation risks and benefits in CKD patients with AF
The risk of both stroke and haemorrhage increases as chronic kidney disease progresses, which can complicate the decision on whether to begin anticoagulation in those with concomitant atrial fibrillation.
Source: Clinical Pharmacist - March 28, 2018 Category: Drugs & Pharmacology Source Type: research
Combining statins and antihypertensives boosts stroke prevention
Researchers investigated the efficacy of combined treatment in patients with a risk of cardiovascular diseases
Source: Clinical Pharmacist - February 23, 2018 Category: Drugs & Pharmacology Source Type: research
Stroke: classification and diagnosis
In light of the many pressures currently facing the NHS, as well as an ever increasing ageing population, pharmacists and healthcare professionals should be aware of the risk factors for stroke, its classification and diagnosis.
Source: Clinical Pharmacist - January 10, 2018 Category: Drugs & Pharmacology Source Type: research
Discontinuing statins after stroke increases risk of another
Stopping statin therapy after ischaemic stroke should be discouraged to avoid increased risk of another stroke.
Source: Clinical Pharmacist - August 21, 2017 Category: Drugs & Pharmacology Source Type: research
Proton pump inhibitors may increase risk of first stroke
Data from 244,679 patients that had undergone endoscopy show that stroke incidence was 19% higher in patients who filed a prescription for a PPI compared with those with no PPI exposure
Source: Clinical Pharmacist - December 29, 2016 Category: Drugs & Pharmacology Source Type: research
Statins effective at preventing first heart attack or stroke
Statins were associated with a 36% lower risk of heart attack and 29% lower risk of stroke compared with placebo in a review of data from more than 70,000 patients.
Source: Clinical Pharmacist - December 19, 2016 Category: Drugs & Pharmacology Source Type: research
Pharmacist-led atrial fibrillation reviews reduce stroke risk for patients
A review scheme led by a team of pharmacists prevented an estimated 886 strokes in patients with atrial fibrillation.
Source: Clinical Pharmacist - October 31, 2016 Category: Drugs & Pharmacology Source Type: research
'Don ’t wait to anticoagulate' project
I was interested to read the news story ‘Many atrial fibrillation patients at risk of stroke treated with aspirin over anticoagulants’ (The Pharmaceutical Journal online, 24 June 2016), which outlines the finding that significant numbers of patients with atrial fibrillation (AF) are not being prescribed the most effective form of .. .
Source: Clinical Pharmacist - August 3, 2016 Category: Drugs & Pharmacology Source Type: research
